What is Boca Biolistics?
Boca Biolistics operates as a critical node in the global healthcare research supply chain, specializing in the procurement of high-quality biospecimens including biofluids, tissues, and whole blood. By leveraging a sophisticated network of over 120 collection sites spanning 50 countries, the company provides researchers with the raw materials necessary to advance studies in oncology, infectious diseases, and autoimmune conditions. Their integrated service model, which encompasses central laboratory testing and clinical research support, positions them as a vital partner for pharmaceutical entities seeking to accelerate the development of life-changing therapies. Through rigorous quality control and a vast, diverse donor network, Boca Biolistics facilitates the translation of scientific discovery into clinical application, effectively bridging the gap between laboratory research and patient-centric outcomes.
How much funding has Boca Biolistics raised?
Boca Biolistics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Boca Biolistics
PPP
Public-Private Partnership
What's next for Boca Biolistics?
With this latest infusion of capital, Boca Biolistics is well-positioned to enhance its operational footprint and technological infrastructure. The strategic focus will likely shift toward optimizing its global collection network and integrating advanced diagnostic methodologies to meet the increasing demand for precision medicine. As the company navigates the complexities of late-stage growth, it remains focused on scaling its service offerings to support the evolving needs of the IVD and pharmaceutical sectors. By prioritizing innovation in biospecimen management and expanding its therapeutic focus areas, Boca Biolistics aims to maintain its competitive edge in the high-stakes environment of global clinical research, ensuring that researchers have the reliable, high-integrity data required to drive the next generation of medical breakthroughs.
See full Boca Biolistics company page
